We are live on ! Find out more
UTMD icon

Utah Medical Products
UTMD

72 hedge funds and large institutions have $241M invested in Utah Medical Products in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 24 increasing their positions, 24 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

9% more capital invested

Capital invested by funds: $221M → $241M (+$20.6M)

6% more funds holding

Funds holding: 68 → 72 (+4)

0.06% more ownership

Funds ownership: 71.22% → 71.28% (+0.06%)

0% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 24

Holders
72
Holders Change
+4
Holders Change %
+5.88%
% of All Funds
1.26%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
24
Reduced
24
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HP
HealthInvest Partners
Sweden
+$3.71M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.89M
3
Wells Fargo
Wells Fargo
California
+$552K
4
RIM
Ranger Investment Management
Texas
+$434K
5
MAM
Martingale Asset Management
Massachusetts
+$319K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.46M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.23M
3
BlackRock
BlackRock
New York
-$758K
4
Russell Investments Group
Russell Investments Group
United Kingdom
-$515K
5
LCM
Legato Capital Management
California
-$473K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$1.1M +$552K +6,250 +112%
SCP
27
Seizert Capital Partners
Michigan
$968K -$45K -509 -5%
CCMINC
28
Cardinal Capital Management Inc (North Carolina)
North Carolina
$937K +$6.01K +68 +0.7%
Mercer Global Advisors
29
Mercer Global Advisors
Colorado
$890K – – –
BIP
30
Brandes Investment Partners
California
$857K -$40K -453 -5%
PPA
31
Parametric Portfolio Associates
Washington
$729K +$95.1K +1,077 +16%
GC
32
Globeflex Capital
California
$588K – – –
SO
33
STRS Ohio
Ohio
$547K – – –
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$468K +$15.5K +175 +4%
PAM
35
Panagora Asset Management
Massachusetts
$460K – – –
AllianceBernstein
36
AllianceBernstein
Tennessee
$436K – – –
Royal Bank of Canada
37
Royal Bank of Canada
Ontario, Canada
$435K +$37.3K +422 +10%
PIM
38
Penobscot Investment Management
Massachusetts
$371K – – –
Invesco
39
Invesco
Georgia
$362K +$26.4K +299 +8%
Los Angeles Capital Management
40
Los Angeles Capital Management
California
$342K -$39.8K -450 -11%
MAM
41
Martingale Asset Management
Massachusetts
$336K +$319K +3,606 New
ASN
42
Advisory Services Network
Georgia
$307K +$88 +1 +0%
Deutsche Bank
43
Deutsche Bank
Germany
$287K -$12.9K -146 -5%
FQ
44
First Quadrant
California
$286K +$241K +2,733 +785%
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$263K +$618 +7 +0.2%
Envestnet Asset Management
46
Envestnet Asset Management
Illinois
$243K – – –
Manulife (Manufacturers Life Insurance)
47
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$233K -$18.8K -213 -8%
OSAM
48
O'Shaughnessy Asset Management
Connecticut
$224K +$42.4K +480 +25%
SG Americas Securities
49
SG Americas Securities
New York
$189K +$180K +2,039 New
AIG
50
American International Group
New York
$174K -$3.89K -44 -2%
1
2
3

UTMD Hedge Fund Activity: Q3 2021 in Review

72 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q3 2021, worth a combined $241M — up 9.3% from $221M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new UTMD positions and 2 closed out — a net gain of 4 holders — while 24 added to existing stakes and 24 trimmed.

The largest buyer was HealthInvest Partners, opening a new position worth an estimated $3.71M. The largest seller was Fidelity Investments, cutting an estimated $3.46M.

  • 72 institutional investors held Utah Medical Products (UTMD) as of Q3 2021, up from 68 in Q2 2021.
  • Funds reported $241M of Utah Medical Products stock for Q3 2021, up 9.3% quarter-over-quarter.
  • 6 funds opened new Utah Medical Products positions in Q3 2021 and 2 closed out, a net change of +4 holders.
  • The largest Utah Medical Products buyer in Q3 2021 was HealthInvest Partners, an estimated $3.71M added.
  • The largest Utah Medical Products seller in Q3 2021 was Fidelity Investments, an estimated $3.46M sold.

Based on aggregated 13F filings for Q3 2021.